BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma

NCT07002216 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma
Advanced Hodgkin Lymphoma

Interventions

DRUG: Brentuximab Vedotin
DRUG: Etoposide
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Dacarbazine
DRUG: Dexamethasone

Sponsor

University of Miami

Collaborators

[object Object]